CompletedPhase 4NCT04349826
The Azithromycin and Cefixime Treatment of Typhoid in South Asia Trial (ACT-South Asia Trial)
Studying Typhoid
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Oxford University Clinical Research Unit, Vietnam
- Principal Investigator
- Buddha Basnyat, MBBS,Msc,MDUniversity of Oxford
- Intervention
- Azithromycin(drug)
- Enrollment
- 2150 target
- Eligibility
- 2-65 years · All sexes
- Timeline
- 2021 – 2025
Study locations (1)
- Patan Hospital, Lalitpur, Bagmati, Nepal
Collaborators
University of Oxford · Medical Research Council · Department for International Development, United Kingdom · Wellcome Trust
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04349826 on ClinicalTrials.govOther trials for Typhoid
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT04083950Induction of Gut Permeability by an Oral VaccineUSDA, Western Human Nutrition Research Center
- ACTIVE NOT RECRUITINGPHASE3NCT03299426Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, MalawiUniversity of Maryland, Baltimore
- ACTIVE NOT RECRUITINGPHASE4NCT03970304CVD 37000: Immunity and Microbiome Studies at Intestinal and Systemic Sites in Ty21a Vaccinated AdultsUniversity of Maryland, Baltimore